Tarpeyo
Generic name: Budesonide
Dosage form: Delayed-release oral capsule
Drug class:
Glucocorticoids
Usage of Tarpeyo
Tarpeyo (buDesonide) is an oral, delayed-release, corticosteroid capsule that may be used to reduce inflammation and the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression.
IgAN is a common disease of the kidneys with a high risk of progression to end-stage renal disease (ESRD), especially in certain ethnicities. Galactose deficient IgA1(Gd-IgA1), produced by the mucosal B-cells present in the ileum (the final portion of the small intestine) is critical for the development and progression of the condition. Tarpeyo (Budesonide) has anti-inflammatory and immunosuppressive effects and works by modulating mucosal B-cell numbers and activity.
Tarpeyo was first FDA-approved on December 15, 2021, under the accelerated approval designation. It received full approval on December 20, 2023, and was the first treatment that significantly reduces the loss of kidney function in IgA nephropathy to be approved.
Tarpeyo side effects
Get emergency medical help if you have signs of an allergic reaction to Tarpeyo: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tarpeyo may cause serious side effects, including:
Common Tarpeyo side effects affecting 5% or more of the population include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to Calliditas Therapeutics at 1-844-IGA-0011 or the FDA at 1-800-FDA-1088.
Before taking Tarpeyo
To make sure Tarpeyo is safe for you, tell your doctor if you:
Pregnancy
Tarpeyo may harm your unborn baby. Talk to your healthcare provider about the possible risk to your unborn baby if you take Tarpeyo when you are pregnant.
Breastfeeding
It is not known if Tarpeyo passes into your breast milk or if it will affect your baby. Talk to your healthcare provider about the best way to feed your baby during treatment. Your healthcare provider should regularly monitor how fast your baby grows if you are taking Tarpeyo and breastfeeding.
Relate drugs
- A-Hydrocort
- Alkindi Sprinkle
- A-Methapred
- A-Methapred injection
- Aristocort
- Aristocort Forte
- Aristospan
- Azmacort
- Clinacort
- Cortef
- Cortenema foam, enema
- Cortifoam foam, enema
- Cortisone
- Cotolone
- Baycadron Elixer
- Betamethasone injection
- Betamethasone sodium phosphate and betamethasone acetate
- Bubbli-Pred
- Celestone Soluspan
- Celestone Soluspan injection
- De-Sone LA injection
- Decadron
- Decadron injection
- Deflazacort
- Dekpak 13 Day Taperpak
- Deltasone
- Depo-Medrol
- Depo-Medrol injection
- Dexabliss 11-Day Dose Pack
- Dexamethasone
- Dexamethasone (Oral)
- Dexamethasone injection
- Dexamethasone Intensol
- DexPak
- DexPak 10 Day TaperPak
- DexPak 6 DayTaperpak
- DexPak Jr
- Dxevo 11-Day Dose Pack
- Emflaza
- Entocort EC
- Flo-Pred
- Hemady
- Hexatrione injection
- HiDex 6-Day Taper Package
- Hydrocortisone
- Hydrocortisone (Oral)
- Hydrocortisone injection
- Hydrocortisone rectal foam, enema
- Kenalog-10
- Kenalog-10 injection
- Kenalog-40
- Kenalog-80 injection
- Medrol
- Medrol Dosepak
- Methylpred-DP
- Methylprednisolone
- Methylprednisolone (Oral)
- MethylPREDNISolone Dose Pack
- Methylprednisolone injection
- Millipred
- Millipred DP
- Orapred ODT
- Ortikos
- Pediapred
- Prednicot
- Prednisolone
- Prednisolone (Oral)
- Prednisone
- Prednisone Intensol
- Prelone
- Rayos
- Solu-CORTEF injection
- Solu-MEDROL injection
- SoluCORTEF
- SoluMEDROL
- Sterapred
- Sterapred DS
- TaperDex 12-Day
- TaperDex 6-Day
- TaperDex 7-Day
- Tarpeyo
- Triam-Forte
- Triamcinolone
- Triamcinolone (Intra-articular)
- Triamcinolone injection
- Triamcot (Triamcinolone Injection)
- Triesense
- Uceris
- Uceris (Budesonide Oral)
- Uceris (Budesonide Rectal)
- Veripred 20
- Zcort 7-Day
- Zema-Pak
- Zilretta
How to use Tarpeyo
The recommended dosage is 16mg once a day, administered orally (by mouth).
The recommended duration of therapy is 9 months. When discontinuing therapy, your healthcare provider should reduce the dosage to 8 mg once daily for the last 2 weeks of therapy.
Warnings
You should not use Tarpeyo if you are allergic to budesonide or any of the ingredients in the delayed-release capsules.
Long-term, regular use of corticosteroids can cause hypercorticism and adrenal axis suppression, which reduces the response of the hypothalamus-pituitary-adrenal (HPA) axis to stress. During surgery, illness, or other stressful events, supplementation with additional corticosteroids may be required. Your healthcare provider will monitor you for HPA suppression when tapering Tarpeyo. People with moderate to severe liver disease may be more at risk; do not use in those with severe liver disease.
Tarpeyo can suppress the immune system and make you more vulnerable to infection and disease. Avoid using Tarpeyo in patients with active or latent tuberculosis infection, untreated fungal, bacterial, systemic viral or parasitic infections, or herpes simplex of the eye. May affect the response to vaccines. Tell your doctor about any illness or infection you had within the past several weeks.
Tarpeyo can cause side effects that may worsen other pre-existing conditions, such as high blood pressure, diabetes, osteoporosis, glaucoma, or cataracts. Your healthcare provider will monitor you for any worsening of your condition.
It is not known if Tarpeyo is safe and effective in children.
What other drugs will affect Tarpeyo
Tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following:
This list is not complete. Other drugs may interact with budesonide, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions